Anika Therapeutics Financial Overview
Anika Therapeutics's market cap is currently $139.02M. The company's EPS TTM is $0.04; its P/E ratio is ―; Anika Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
